Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1973 Jan;26(1):60–69. doi: 10.1136/jcp.26.1.60

Lysozyme activity and nitroblue-tetrazolium reduction in leukaemic cells

D Catovsky 1, D A G Galton 1
PMCID: PMC477651  PMID: 4511938

Abstract

The cytochemical methods for lysozyme and nitroblue-tetrazolium reduction have been used to study the blast cells of acute myeloid leukaemia. Both proved useful in characterizing the cases with predominant monocytic differentiation.

The demonstration of lysozyme activity helped to define two main groups: (a) with predominantly lysozyme-negative cells (myeloblastic-promyelocytic), and (b) with considerable numbers of positive cells (monoblastic-monocytic). In addition this test was also of value in the differentiation of other leukaemic disorders. Reduction of nitroblue-tetrazolium was also a feature of monocytic differentiation. The combination of these two methods with those for myeloperoxidase and non-specific esterase activity contributes to the cytological characterization of acute myeloid leukaemia.

Full text

PDF
60

Images in this article

62Image
on p.62
62Image
on p.62
62Image
on p.62
63Image
on p.63
63Image
on p.63
63Image
on p.63
64Image
on p.64
64Image
on p.64
64Image
on p.64
66Image
on p.66
66Image
on p.66
67Image
on p.67

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asamer H., Schmalzl F., Braunsteiner H. Immunocytological demonstration of lysozyme (muramidase) in human leukaemic cells. Br J Haematol. 1971 Jun;20(6):571–574. doi: 10.1111/j.1365-2141.1971.tb00795.x. [DOI] [PubMed] [Google Scholar]
  2. Briggs R. S., Perillie P. E., Finch S. C. Lysozyme in bone marrow and peripheral blood cells. J Histochem Cytochem. 1966 Feb;14(2):167–170. doi: 10.1177/14.2.167. [DOI] [PubMed] [Google Scholar]
  3. Catovsky D., Galton D. A. Cytochemical demonstration of lysozyme and nitroblue tetrazolium reduction in leukaemia monocytes. Br J Haematol. 1972 May;22(5):634–635. [PubMed] [Google Scholar]
  4. Catovsky D., Galton D. A., Griffin C. The significance of lysozyme estimations in acute myeloid and chronic monocytic leukaemia. Br J Haematol. 1971 Nov;21(5):565–580. doi: 10.1111/j.1365-2141.1971.tb02718.x. [DOI] [PubMed] [Google Scholar]
  5. Catovsky D., Galton D. A., Robinson J. Myeloperoxidase-deficient neutrophils in acute myeloid leukaemia. Scand J Haematol. 1972;9(2):142–148. doi: 10.1111/j.1600-0609.1972.tb00923.x. [DOI] [PubMed] [Google Scholar]
  6. Daniel M. T., Flandrin G., Lejeune F., Liso P., Lortholary P. I. Les estérases spécifiques monocytaires. Utilisation dans la classification des leucémies aiguës. Nouv Rev Fr Hematol. 1971 Mar-Apr;11(2):233–239. [PubMed] [Google Scholar]
  7. Goldman J. M., Catovsky D. The function of the phagocytic leucocytes in leukaemia. Br J Haematol. 1972 Sep;23(Suppl):223–230. doi: 10.1111/j.1365-2141.1972.tb03522.x. [DOI] [PubMed] [Google Scholar]
  8. Nathan D. G., Baehner R. L., Weaver D. K. Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest. 1969 Oct;48(10):1895–1904. doi: 10.1172/JCI106156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966 Nov 1;124(5):921–952. doi: 10.1084/jem.124.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ota H., Nagase H. Serial estimation of serum, urine, and leukocyte muramidase (lysozyme) in monocytic leukemia. Acta Haematol. 1971;46(5):257–266. doi: 10.1159/000208584. [DOI] [PubMed] [Google Scholar]
  11. PARRY R. M., Jr, CHANDAN R. C., SHAHANI K. M. A RAPID AND SENSITIVE ASSAY OF MURAMIDASE. Proc Soc Exp Biol Med. 1965 Jun;119:384–386. doi: 10.3181/00379727-119-30188. [DOI] [PubMed] [Google Scholar]
  12. Park B. H., Fikrig S. M., Smithwick E. M. Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid. Lancet. 1968 Sep 7;2(7567):532–534. doi: 10.1016/s0140-6736(68)92406-9. [DOI] [PubMed] [Google Scholar]
  13. Park H. H., Good R. A. N.B.T. test stimulated. Lancet. 1970 Sep 19;2(7673):616–616. doi: 10.1016/s0140-6736(70)90207-2. [DOI] [PubMed] [Google Scholar]
  14. Schmalzl F., Braunsteiner H. The application of cytochemical methods to the study of acute leukemia. A review. Acta Haematol. 1971;45(4):209–217. doi: 10.1159/000208627. [DOI] [PubMed] [Google Scholar]
  15. Schmalzl F., Braunsteiner H. [On the origin of monocytes]. Acta Haematol. 1968;39(3):177–182. doi: 10.1159/000208959. [DOI] [PubMed] [Google Scholar]
  16. Syrén E., Raeste A. M. Identification of blood monocytes by demonstration of lysozyme and peroxidase activity. Acta Haematol. 1971;45(1):29–35. doi: 10.1159/000208604. [DOI] [PubMed] [Google Scholar]
  17. WACHSTEIN M., WOLF G. The histochemical demonstration of esterase activity in human blood and bone marrow smears. J Histochem Cytochem. 1958 Nov;6(6):457–457. doi: 10.1177/6.6.457. [DOI] [PubMed] [Google Scholar]
  18. Wiernik P. H., Serpick A. A. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am J Med. 1969 Mar;46(3):330–343. doi: 10.1016/0002-9343(69)90036-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES